Gemcitabine and Pazopanib in Metastatic Pancreatic Cancer

NCT01080248 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Closed due to delay by GSK

Conditions

Pancreatic Cancer

Interventions

DRUG: Gemcitabine
DRUG: Pazopanib

Sponsor

Washington University School of Medicine